Tier 2 Dermatology Service for Mid and South Essex

Official notice

Authority: NHS Mid and South Essex Integrated Care Board (NHS & healthcare)

ServicesAward procedure without prior publication of a call for competition

Sectors: Health & Social Care (85) Delivery: East of England (UKH3)

Awarded value£809,230published contract · exc. VAT

Awarded 2 Jan 2024no call for competition

Awarded to Mayflower Healthcare Alliance Limited2 awards

What is being bought

Published requirement description

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £809,230.

This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037586) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020).

In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.)

CPV: Health services

The lotProcurement structure

single lot · no lot value published

Lot #1Awarded

Delivery: East of England

Procedure terms & legal framework

From the official record

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Services
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Unspecified in notice
Recurring procurement: Unspecified in notice
First published: 21 Dec 2023, 08:34 GMT
Last source update: 16 Jan 2024, 20:33 GMT
Authority reference: ACE-0717-2023-MSE
FTS notice number: 2024/S 000-001535
Classification (CPV): Health services
Delivery area: East of England (UKH3)
Official registry OCID: ocds-h6vhtk-0428f7 Find a Tender

Why no open competition: Extreme urgency brought about by events unforeseeable for the contracting authority/entity and in accordance with the strict conditions stated in the directive
Published justification: As detailed in the voluntary ex-ante notice (Notice Number: 2023/S 000-037586) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020).
In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.)
The Authority has taken a decision to award a contract to the incumbent provider as it is considered to be the most technically capable provider in the current environment, whilst the ICB undergoes this transition period, to ensure quality, safety and consistency in provision of care that meet the needs of the population during this transition period. The Authority will publish appropriate Notices accordingly to communicate any such future changes to the market, once final.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 2

Awarded value £809,2301 contract exc. VAT · 1 repeated publication of the same award counted once

Bids received 1

Contracts signed 2latest 2 Jan 2024

Awarded to	Value	Date	Status
Mayflower Healthcare Alliance Limited	£809,230 †same award published again · counted once	—	Awarded
Mayflower Healthcare Alliance LimitedSubcontracting: declared	£809,230 †	—	Awarded

Contracts

Contract 001535-2024-1 · Mayflower Healthcare Alliance Limited
Signed
2 Jan 2024
Value
£809,230
Status
active
Contract 037586-2023-1 · Mayflower Healthcare Alliance Limited
Signed
16 Oct 2023
Value
£809,230
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
1bids	—	—	—

Contracting authority & participating public bodies

NHS Mid and South Essex Integrated Care Board

Contracting authorityNHS & healthcareBody governed by public lawHealth Phoenix House, Christopher Martin Rd,, Basildon, East of England, SS14 3HGContact name, email

Dispute resolution & review bodies

High Court Justice of England and WalesReview body London
High Court of Justice of England and WalesReview body London

Bidders & participating suppliers

1 commercial party on the notice

Mayflower Healthcare AllianceAwarded supplier Kingsman Farm Tye Common Road, Billericay, East of England, CM12 9PZ

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.